Conference
HIGH-DOSE EPIRUBICIN (E) GIVEN AS A DAILY X 3 SCHEDULE IN PATIENTS (PTS) WITH UNTREATED EXTENSIVE NON-SMALL CELL LUNG-CANCER (NSCLC) - A PHASE-I-II STUDY
Authors
FELD R; WIERZBICKI R; WALDE D; SHEPHERD F; EVANS WK; BURKES R; HOLLOWAY C; LASSUS M
Volume
29
Pagination
pp. 208-208
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
March 1, 1988
Conference proceedings
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH
ISSN
0197-016X